Public research preview

John Curtis, Representative disclosure: Abbott Laboratories Common Stock (ABT)

Disclosed a sell transaction in Abbott Laboratories Common Stock (ABT). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.

Copy Window
Probably too late
24/100
Signal Quality
37/100
Data quality
93%
High quality

This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.

Evidence passport

Official-source context and parser confidence before any simulation or alert decision.

Source
House STOCK Act disclosures
Published
9 Nov 2022, 00:00
Parser confidence
94%
Instrument mapping
95%
Filing delay
19 days

Timeline

Transaction date

21 Oct 2022

Public disclosure

9 Nov 2022

Now

Tracked today

Filing delay: 19 days

Price movement

Complete coverage

Provider
Yahoo Finance daily close
Fetched
10 Jun 2026

Stock path

ABT from pre-transaction context through latest close.

Transaction

21 Oct 2022 · 88.665 USD · Not public yet

System decision

Would not buyThe strategy's filters reject this signal. Failed filters: Buy disclosure.

Would not buy82.6109.7136.8USDDate21 Oct9 Nov8 JunOfficial disclosure9 NovTransactionDisclosureLatest
  • Not public yet
  • Would not buy
Observed transaction close
88.665
Observed disclosure close
92.769
Observed latest close
90.5
Pre-disclosure move
+4.6%
Post-disclosure move
-2.4%
Market-adjusted move
-2.4%
1w since disclosure
+4.2%
1m since disclosure
+8.1%
3m since disclosure
+13.1%
Pre-disclosure peak run-up
+4.8%
Retrace from peak
-0.2%

Why Copy Window is Probably too late

Supporting factors

  • Parsed sell disclosure for ordinary shares from House STOCK Act disclosures.
  • Reported amount is $1,001 - $15,000.
  • Post-disclosure move is calculated from Yahoo Finance daily close daily closes.

Cautions

  • Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
  • Review the original source document before making any investment decision.

Source document

House STOCK Act disclosures, published 9 Nov 2022, 00:00

View source
Parser confidence
94%
Instrument mapping
95%
FieldExtracted value
roleRepresentative
sidesell
value1001
sourcehouse_stock_act
tickerABT
chamberHouse
currencyUSD
assetTypestock
sourceUrlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/20021965.pdf
personNameJohn Curtis
amountRange$1,001 - $15,000
companyNameAbbott Laboratories (ABT)
publishedAt2022-11-09T00:00:00.000Z
rawDocumentIdraw-us-house-20021965-0
disclosureDate2022-11-09
transactionDate2022-10-21
transactionTypeS (partial)